TNL Mediagene (TNMG) Form 6-K — Oct 21, 2026
TNL Mediagene (Nasdaq: TNMG) signed a $6.25 million securities purchase agreement with Vector Advisory Partners LLC on October 19, 2026, for newly authorized Series A and Series B convertible preferred shares priced at $1.66449 per share, with a $1.5 million non-refundable signing payment already received and $4.75 million due at closing within roughly ten days. Before shareholder, Nasdaq, and Cayman approvals, the Series A shares represent only about 19.99% of fully diluted shares as-converted; upon receipt of the Requisite Approvals, the preferred converts into approximately 80% of fully diluted ordinary shares, resulting in a change of control.
Key figures
- Debt Amount
- 3856766
- Deal Value Usd
- 6250000
- Gross Proceeds
- 6250000
- Offering Price
- 1.66449
- Closing payment
- 4750000
- Series a shares
- 938257
- Series b shares
- 2816647
- Signing payment
- 1500000
- Closing deadline
- 10th calendar day after October 19, 2026 effective date
- Series a allocation
- 1561719.35
- Series b allocation
- 4688280.65
- Liquidation preference
- 1.0x non-participating
- Operating transition reserve
- 750000
- Issuer repurchase reserve max
- 800000
- Pre approval as converted pct
- 19.99%
- Post approval as converted pct
- 80%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.